Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 253

1.

Determination of reliable lung function parameters in intubated mice.

Bonnardel E, Prevel R, Campagnac M, Dubreuil M, Marthan R, Berger P, Dupin I.

Respir Res. 2019 Sep 14;20(1):211. doi: 10.1186/s12931-019-1177-9.

PMID:
31521163
2.

Quantification of 18F-DCFPyL Uptake: TBR versus Patlak's Analysis.

Laffon E, de Clermont-Gallerande H, Marthan R.

J Nucl Med. 2019 Aug 26. pii: jnumed.119.232926. doi: 10.2967/jnumed.119.232926. [Epub ahead of print] No abstract available.

PMID:
31451485
3.

Reversibility of 68Ga-FAPI-2 trapping might prove an asset for PET quantitative imaging.

Laffon E, Marthan R.

J Nucl Med. 2019 Aug 16. pii: jnumed.119.234393. doi: 10.2967/jnumed.119.234393. [Epub ahead of print] No abstract available.

PMID:
31420500
4.

Fibrocyte accumulation in the airway walls of COPD patients.

Dupin I, Thumerel M, Maurat E, Coste F, Eyraud E, Begueret H, Trian T, Montaudon M, Marthan R, Girodet PO, Berger P.

Eur Respir J. 2019 Sep 5;54(3). pii: 1802173. doi: 10.1183/13993003.02173-2018. Print 2019 Sep.

PMID:
31196946
5.

Correction to: Comparison of three-parameter kinetic model analysis to standard Patlak's analysis in 18F-FDG PET imaging of lung cancer patients.

Laffon E, Calcagni ML, Galli G, Giordano A, Capotosti A, Marthan R, Indovina L.

EJNMMI Res. 2019 Mar 26;9(1):30. doi: 10.1186/s13550-019-0495-8.

6.

Quantitative CT assessment of bronchial and vascular alterations in severe precapillary pulmonary hypertension.

Coste F, Benlala I, Dournes G, Dromer C, Blanchard E, Girodet PO, Montaudon M, Baldacci F, Picard F, Marthan R, Laurent F, Berger P.

Int J Chron Obstruct Pulmon Dis. 2019 Feb 11;14:381-389. doi: 10.2147/COPD.S177638. eCollection 2019.

7.

Relevance of Measurement Uncertainty for Quantitative Response Assessment of Breast Cancer Bone Metastases with 18F-Fluoride.

Laffon E, Marthan R.

J Nucl Med. 2019 Apr;60(4):568. doi: 10.2967/jnumed.119.226092. Epub 2019 Feb 7. No abstract available.

PMID:
30733321
8.

Stretch-activated Piezo1 Channel in Endothelial Cells Relaxes Mouse Intrapulmonary Arteries.

Lhomme A, Gilbert G, Pele T, Deweirdt J, Henrion D, Baudrimont I, Campagnac M, Marthan R, Guibert C, Ducret T, Savineau JP, Quignard JF.

Am J Respir Cell Mol Biol. 2019 Jun;60(6):650-658. doi: 10.1165/rcmb.2018-0197OC.

PMID:
30562052
9.

Performance of 18F-FDG PET/MRI and 18F-FDG PET/CT for T and N staging in patients with non-small-cell lung cancer.

Laffon E, Marthan R.

Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):522-523. doi: 10.1007/s00259-018-4201-2. Epub 2018 Oct 30. No abstract available.

PMID:
30377737
10.

Clinical and economic burden of severe asthma: A French cohort study.

Nordon C, Grimaldi-Bensouda L, Pribil C, Nachbaur G, Amzal B, Thabut G, Marthan R, Aubier M; COBRA Study Group.

Respir Med. 2018 Nov;144:42-49. doi: 10.1016/j.rmed.2018.10.002. Epub 2018 Oct 2.

PMID:
30366583
11.

Could we avoid computing TMTV of DLBCL patients in routine practice?

Laffon E, Marthan R.

Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2235-2237. doi: 10.1007/s00259-018-4097-x. Epub 2018 Jul 28. No abstract available.

PMID:
30056545
12.

ORAI Channels as Potential Therapeutic Targets in Pulmonary Hypertension.

Rode B, Bailey MA, Marthan R, Beech DJ, Guibert C.

Physiology (Bethesda). 2018 Jul 1;33(4):261-268. doi: 10.1152/physiol.00016.2018. Review.

13.

Optimal method for measuring baseline metabolic tumor volume in DLBCL patients: are statistical agreements of SUV ≥2.5 satisfactory?

Laffon E, Marthan R.

Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1832-1833. doi: 10.1007/s00259-018-4049-5. Epub 2018 May 17. No abstract available.

PMID:
29770849
14.

Should we assess repeatability of PET quantitative uptake measurements of each 18F-labelled tracer?

Laffon E, de Clermont H, Buj S, Marthan R.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1272-1273. doi: 10.1007/s00259-018-4006-3. Epub 2018 Apr 17. No abstract available.

PMID:
29666891
15.

Comparison of three-parameter kinetic model analysis to standard Patlak's analysis in 18F-FDG PET imaging of lung cancer patients.

Laffon E, Calcagni ML, Galli G, Giordano A, Capotosti A, Marthan R, Indovina L.

EJNMMI Res. 2018 Mar 27;8(1):24. doi: 10.1186/s13550-018-0369-5. Erratum in: EJNMMI Res. 2019 Mar 26;9(1):30.

16.

Montelukast reverses airway remodeling in actively sensitized young mice.

Debelleix S, Siao-Him Fa V, Begueret H, Berger P, Kamaev A, Ousova O, Marthan R, Fayon M.

Pediatr Pulmonol. 2018 Jun;53(6):701-709. doi: 10.1002/ppul.23980. Epub 2018 Mar 1.

PMID:
29493871
17.

6″-18F-Fluoromaltotriose PET Evaluation in Escherichia Coli-Induced Myositis: Is There Uptake Saturation in Control?

Laffon E, Marthan R.

J Nucl Med. 2018 Jul;59(7):1166. doi: 10.2967/jnumed.118.208645. Epub 2018 Feb 15. No abstract available.

18.

A three-time-point method for assessing kinetic parameters of 64Cu-labeled Ramucirumab trapping in VEGFR-2 positive lung tumors.

Laffon E, Marthan R.

Phys Med. 2017 Nov;43:1-5. doi: 10.1016/j.ejmp.2017.10.001. Epub 2017 Oct 9.

PMID:
29195550
19.

On the 18F-fluoride PET imaging quantification to predict 223Ra-dichloride treatment response.

Laffon E, de Clermont H, Marthan R, Paycha F.

Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):318-320. doi: 10.1007/s00259-017-3868-0. Epub 2017 Nov 4. No abstract available.

PMID:
29103200
20.

Involvement of oxidative stress and calcium signaling in airborne particulate matter - induced damages in human pulmonary artery endothelial cells.

Deweirdt J, Quignard JF, Crobeddu B, Baeza-Squiban A, Sciare J, Courtois A, Lacomme S, Gontier E, Muller B, Savineau JP, Marthan R, Guibert C, Baudrimont I.

Toxicol In Vitro. 2017 Dec;45(Pt 3):340-350. doi: 10.1016/j.tiv.2017.07.001. Epub 2017 Jul 5.

PMID:
28688989
21.

Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis: MR Imaging of Airway Mucus Contrasts as a Tool for Diagnosis.

Dournes G, Berger P, Refait J, Macey J, Bui S, Delhaes L, Montaudon M, Corneloup O, Chateil JF, Marthan R, Fayon M, Laurent F.

Radiology. 2017 Oct;285(1):261-269. doi: 10.1148/radiol.2017162350. Epub 2017 May 22.

PMID:
28530849
22.

FDG PET for therapy monitoring in Hodgkin's and non-Hodgkin's lymphomas: qPET versus rPET.

Laffon E, Marthan R.

Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1602-1603. doi: 10.1007/s00259-017-3719-z. Epub 2017 May 18. No abstract available.

PMID:
28523358
23.

Measurement uncertainty of lesion and reference mediastinum standardized uptake value in lung cancer.

Laffon E, Milpied N, Marthan R.

Nucl Med Commun. 2017 Jun;38(6):509-514. doi: 10.1097/MNM.0000000000000677.

PMID:
28489690
24.

T-type voltage gated calcium channels are involved in endothelium-dependent relaxation of mice pulmonary artery.

Gilbert G, Courtois A, Dubois M, Cussac LA, Ducret T, Lory P, Marthan R, Savineau JP, Quignard JF.

Biochem Pharmacol. 2017 Aug 15;138:61-72. doi: 10.1016/j.bcp.2017.04.021. Epub 2017 Apr 22.

PMID:
28438566
25.

Chronic hypoxia aggravates monocrotaline-induced pulmonary arterial hypertension: a rodent relevant model to the human severe form of the disease.

Coste F, Guibert C, Magat J, Abell E, Vaillant F, Dubois M, Courtois A, Diolez P, Quesson B, Marthan R, Savineau JP, Muller B, Freund-Michel V.

Respir Res. 2017 Mar 14;18(1):47. doi: 10.1186/s12931-017-0533-x.

26.

Altered vasoreactivity in neonatal rats with pulmonary hypertension associated with bronchopulmonary dysplasia: Implication of both eNOS phosphorylation and calcium signaling.

Dumas de la Roque E, Smeralda G, Quignard JF, Freund-Michel V, Courtois A, Marthan R, Muller B, Guibert C, Dubois M.

PLoS One. 2017 Feb 24;12(2):e0173044. doi: 10.1371/journal.pone.0173044. eCollection 2017.

27.

Signaling Pathways Linked to Serotonin-Induced Superoxide Anion Production: A Physiological Role for Mitochondria in Pulmonary Arteries.

Genet N, Billaud M, Rossignol R, Dubois M, Gillibert-Duplantier J, Isakson BE, Marthan R, Savineau JP, Guibert C.

Front Physiol. 2017 Feb 9;8:76. doi: 10.3389/fphys.2017.00076. eCollection 2017.

28.

Cumulated Activity Comparison of 64Cu-/177Lu-Labeled Anti-Epidermal Growth Factor Receptor Antibody in Esophageal Squamous Cell Carcinoma Model.

Laffon E, Thumerel M, Jougon J, Marthan R.

J Nucl Med. 2017 Jun;58(6):888-890. doi: 10.2967/jnumed.116.180521. Epub 2017 Jan 12.

29.

On the Cutoff of Baseline Total Metabolic Tumor Volume in High-Tumor-Burden Follicular Lymphoma.

Laffon E, Marthan R.

J Clin Oncol. 2017 Mar 10;35(8):919-920. doi: 10.1200/JCO.2016.70.6150. Epub 2016 Dec 28. No abstract available.

PMID:
28029314
30.

Calcium signalling induced by in vitro exposure to silicium dioxide nanoparticles in rat pulmonary artery smooth muscle cells.

Dubes V, Parpaite T, Ducret T, Quignard JF, Mornet S, Reinhardt N, Baudrimont I, Dubois M, Freund-Michel V, Marthan R, Muller B, Savineau JP, Courtois A.

Toxicology. 2017 Jan 15;375:37-47. doi: 10.1016/j.tox.2016.12.002. Epub 2016 Dec 7.

PMID:
27939335
31.

Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures in Patients with Non-Small Cell Lung Cancer: Dynamic Versus Test-Retest Design.

Laffon E, Marthan R.

J Nucl Med. 2017 Sep;58(9):1528. doi: 10.2967/jnumed.116.186676. Epub 2016 Dec 8. No abstract available.

32.

Early Assessment of Treatment Response in Takayasu Arteritis: An 18FDG PET Procedure.

Caubet O, Meunier V, Marthan R, Laffon E.

Clin Nucl Med. 2016 Sep;41(9):743-5. doi: 10.1097/RLU.0000000000001261.

PMID:
27280904
33.

Expression and role of connexin-based gap junctions in pulmonary inflammatory diseases.

Freund-Michel V, Muller B, Marthan R, Savineau JP, Guibert C.

Pharmacol Ther. 2016 Aug;164:105-19. doi: 10.1016/j.pharmthera.2016.04.004. Epub 2016 Apr 25. Review.

PMID:
27126473
34.

CT evaluation of small pulmonary vessels area in patients with COPD with severe pulmonary hypertension.

Coste F, Dournes G, Dromer C, Blanchard E, Freund-Michel V, Girodet PO, Montaudon M, Baldacci F, Picard F, Marthan R, Berger P, Laurent F.

Thorax. 2016 Sep;71(9):830-7. doi: 10.1136/thoraxjnl-2015-207696. Epub 2016 Apr 15.

PMID:
27084957
35.

Caveolae are involved in mechanotransduction during pulmonary hypertension.

Gilbert G, Ducret T, Savineau JP, Marthan R, Quignard JF.

Am J Physiol Lung Cell Mol Physiol. 2016 Jun 1;310(11):L1078-87. doi: 10.1152/ajplung.00198.2015. Epub 2016 Mar 25.

36.

Involvement of Heme Oxygenase-1 in particulate matter-induced impairment of NO-dependent relaxation in rat intralobar pulmonary arteries.

Barrier M, Bégorre MA, Baudrimont I, Dubois M, Freund-Michel V, Marthan R, Savineau JP, Muller B, Courtois A.

Toxicol In Vitro. 2016 Apr;32:205-11. doi: 10.1016/j.tiv.2016.01.005. Epub 2016 Jan 9.

PMID:
26780163
37.

Selective dysfunction of p53 for mitochondrial biogenesis induces cellular proliferation in bronchial smooth muscle from asthmatic patients.

Trian T, Allard B, Ozier A, Maurat E, Dupin I, Thumerel M, Ousova O, Gillibert-Duplantier J, Le Morvan V, Begueret H, Girodet PO, Marthan R, Berger P.

J Allergy Clin Immunol. 2016 Jun;137(6):1717-1726.e13. doi: 10.1016/j.jaci.2015.10.031. Epub 2015 Dec 11.

PMID:
26688517
38.

Excess Risk of Cancer from Computed Tomography Scan Is Small but Not So Low as to Be Incalculable.

Dournes G, Marthan R, Berger P, Laurent F.

Am J Respir Crit Care Med. 2015 Dec 1;192(11):1396-7. doi: 10.1164/rccm.201507-1467LE. No abstract available.

PMID:
26623691
39.

Vital Capacity Impairment due to Neuromuscular Disease and its Correlation with Diaphragmatic Ultrasound: A Preliminary Study.

Carrié C, Bonnardel E, Vally R, Revel P, Marthan R, Marthan R.

Ultrasound Med Biol. 2016 Jan;42(1):143-9. doi: 10.1016/j.ultrasmedbio.2015.09.020.

PMID:
26620221
40.

Blood fibrocytes are recruited during acute exacerbations of chronic obstructive pulmonary disease through a CXCR4-dependent pathway.

Dupin I, Allard B, Ozier A, Maurat E, Ousova O, Delbrel E, Trian T, Bui HN, Dromer C, Guisset O, Blanchard E, Hilbert G, Vargas F, Thumerel M, Marthan R, Girodet PO, Berger P.

J Allergy Clin Immunol. 2016 Apr;137(4):1036-1042.e7. doi: 10.1016/j.jaci.2015.08.043. Epub 2015 Oct 23.

PMID:
26602164
41.

SUVpeak Performance in Lung Cancer: Comparison to Average SUV from the 40 Hottest Voxels.

Laffon E, Burger IA, Lamare F, de Clermont H, Marthan R.

J Nucl Med. 2016 Jan;57(1):85-8. doi: 10.2967/jnumed.115.161968. Epub 2015 Nov 12.

42.

Bronchial Smooth Muscle Remodeling in Nonsevere Asthma.

Girodet PO, Allard B, Thumerel M, Begueret H, Dupin I, Ousova O, Lassalle R, Maurat E, Ozier A, Trian T, Marthan R, Berger P.

Am J Respir Crit Care Med. 2016 Mar 15;193(6):627-33. doi: 10.1164/rccm.201507-1404OC.

PMID:
26540234
43.

Role of Nerve Growth Factor in Development and Persistence of Experimental Pulmonary Hypertension.

Freund-Michel V, Cardoso Dos Santos M, Guignabert C, Montani D, Phan C, Coste F, Tu L, Dubois M, Girerd B, Courtois A, Humbert M, Savineau JP, Marthan R, Muller B.

Am J Respir Crit Care Med. 2015 Aug 1;192(3):342-55. doi: 10.1164/rccm.201410-1851OC.

PMID:
26039706
44.

Simplified Methods for Quantification of 18F-Fluoromethylcholine Uptake: Is SUVAUC,PP Actually an SUV?

Laffon E, de Clermont H, Marthan R.

J Nucl Med. 2015 Nov;56(11):1806. doi: 10.2967/jnumed.115.160812. Epub 2015 May 29. No abstract available.

45.

The total amount of uptake may affect the input function: a theoretic approach about 18F-FDG PET imaging.

Laffon E, Marthan R.

Nucl Med Biol. 2015 Sep;42(9):724-7. doi: 10.1016/j.nucmedbio.2015.04.006. Epub 2015 Apr 24.

PMID:
25960434
46.

PET-adapted salvage therapy for Hodgkin's lymphoma.

Laffon E, Marthan R.

Lancet Oncol. 2015 May;16(5):e197-8. doi: 10.1016/S1470-2045(15)70131-2. No abstract available.

PMID:
25943059
47.

Effect of hypoxia on TRPV1 and TRPV4 channels in rat pulmonary arterial smooth muscle cells.

Parpaite T, Cardouat G, Mauroux M, Gillibert-Duplantier J, Robillard P, Quignard JF, Marthan R, Savineau JP, Ducret T.

Pflugers Arch. 2016 Jan;468(1):111-130. doi: 10.1007/s00424-015-1704-6. Epub 2015 Mar 24.

PMID:
25799977
48.

An age-wise comparison of human airway smooth muscle proliferative capacity.

Fayon M, Andrieux A, Bara I, Rebola M, Labbé A, Marthan R, Berger P.

PLoS One. 2015 Mar 23;10(3):e0122446. doi: 10.1371/journal.pone.0122446. eCollection 2015.

49.

Quantitative positron emission tomography imaging for response assessment of [18F]fluorodeoxyglucose-avid lymphomas: should we report standard uptake value confidence limits?

Laffon E, Marthan R.

J Clin Oncol. 2015 Apr 1;33(10):1218-9. doi: 10.1200/JCO.2014.59.6833. Epub 2015 Feb 17. No abstract available.

PMID:
25691673
50.

Human FAM154A (SAXO1) is a microtubule-stabilizing protein specific to cilia and related structures.

Dacheux D, Roger B, Bosc C, Landrein N, Roche E, Chansel L, Trian T, Andrieux A, Papaxanthos-Roche A, Marthan R, Robinson DR, Bonhivers M.

J Cell Sci. 2015 Apr 1;128(7):1294-307. doi: 10.1242/jcs.155143. Epub 2015 Feb 11.

Supplemental Content

Loading ...
Support Center